Columbia biomedical engineers are collaborating with orthopedic surgeons to build a living replacement knee to be tested in clinical trials within five years.
Columbia genome engineers are designing a CRISPR-based gene therapy with potential to prevent blindness in anyone with retinitis pigmentosa, a condition caused by more than 80 different genes.
Neurologist Scott A. Small participated in a Kavli Foundation roundtable on the link between the brain's ability to make new cells and age-related memory loss.
Using stem cells from patients, P&S researchers have created a model of age-related macular degeneration in a dish, which may lead personalized treatments to prevent vision loss.
A Columbia-led research team has clinically validated a new method for predicting time to nursing home residence or death for patients with Alzheimer’s.